Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Vitrafy Life Sciences Ltd. ( (AU:VFY) ).
Vitrafy Life Sciences Limited announced the details for its 2025 Annual General Meeting, which will be held as a hybrid event on November 20, 2025. The meeting will include a Notice of Annual General Meeting, Proxy Form, and Notice and Access Letter. This announcement is part of the company’s ongoing efforts to engage with stakeholders and provide updates on its operations and strategic direction.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Limited is a company specializing in cryopreservation technology that significantly enhances cell survival rates for applications such as blood platelets, cell and gene therapies, aquaculture, and bovine reproduction. The company offers complete cryopreservation solutions through a managed service revenue model, utilizing FDA-registered Smart Freezing and Smart Thawing devices, an integrated LifeChain software platform, and Smart Packaging systems.
Average Trading Volume: 14,706
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$77.26M
Learn more about VFY stock on TipRanks’ Stock Analysis page.